Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian ...

Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, GREECE.

READ THE ORIGINAL POST AT www.physiciansweekly.com